Get your weekly dose of everything in the news about incretin mimetic therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!
Dave Knapp Man On The Mounjaro
Donate to On The Pen: The Weekly Dose
The On The Pen: The Weekly Dose podcast is a fantastic addition to Dave's repertoire of content. As someone who follows him on Instagram but prefers a podcast format, I was thrilled when he announced the launch of this show. It provides the perfect opportunity for me to stay informed and entertained while I'm driving or cleaning. Right from the first episode, it is evident that the production quality is top-notch. The sound is crisp and clear, making for an enjoyable listening experience. Additionally, the inclusion of hyperlinks in the episode notes is greatly appreciated as it allows me to easily access additional resources mentioned during the show.
One of the best aspects of The On The Pen podcast is Dave's ability to simplify complex concepts related to healthcare and make them accessible to anyone. In a field that can often be overwhelming with intricate details, he does an excellent job of breaking down information so that even those without a medical background can understand it. This approach makes his content valuable to a wide range of listeners who are seeking knowledge and empowerment.
Another commendable aspect of this podcast is Dave's fair and unbiased reporting. While there are often controversial topics in healthcare, he remains neutral and presents information objectively. This allows listeners to form their own opinions based on facts rather than feeling swayed by personal biases or agendas.
While it's challenging to find any major flaws in this podcast, one minor criticism would be that some episodes may not cater specifically to individual interests or needs. However, given the variety of topics covered in each episode, it is understandable that not every segment will resonate with every listener. Nevertheless, Dave's engaging style and ability to deliver information effectively compensate for any potential lack of interest in specific topics.
In conclusion, The On The Pen: The Weekly Dose podcast is a must-listen for anyone looking for accessible and informative healthcare content. Dave's dedication to keeping his audience updated with accurate facts while maintaining an engaging delivery style sets this podcast apart. I highly recommend jumping on board early to join the ever-growing community of listeners who appreciate the valuable knowledge and motivation that Dave delivers.
VIEW ALL OF OUR LINKS: https://linktr.ee/manonthemounjaro JOIN OUR SUBSTACK: HTTP://WWW.ONTHEPEN.SUBSTACK.COM
Join the Substack here: onthepen.substack.com Get all my links here: https://linktr.ee/manonthemounjaro
Joe's Petition + All My Links: https://linktr.ee/manonthemounjaro
Dave discussed the latest update in the OFA vs FDA compound tirzepatide battle, as well as this weeks news in obesity medicine. Find our substack and all promotional links here: https://linktr.ee/manonthemounjaro
CVS announces major partnership with Novo Nordisk as Lilly announces Q! 2025 earnings. Dave covers it all in today's breakdown. Join the Substack: https://substack.com/@onthepen WAYS TO SUPPORT MY WORK ⬇️
Join the Substack: https://substack.com/@onthepen WAYS TO SUPPORT MY WORK ⬇️
WAYS TO SUPPORT MY WORK ⬇️
The Knapp family was featured in a health.com video! Watch it Here: https://www.health.com/beyond-obesity-glp1-8685599 WAYS TO SUPPORT MY WORK ⬇️
The Knapp family was featured in a health.com video! Watch it Here: https://www.health.com/beyond-obesity-glp1-8685599 WAYS TO SUPPORT MY WORK ⬇️
The Knapp family was featured in a health.com video! Watch it Here: https://www.health.com/beyond-obesity-glp1-8685599 WAYS TO SUPPORT MY WORK ⬇️
WAYS TO SUPPORT MY WORK ⬇️
WAYS TO SUPPORT MY WORK ⬇️
Ozempic, Trulicity and Victoza are decreasing dementia by 45%, so what is going on with Medicare coverage for obesity medicine? The Knapp family was featured in a health.com video! Watch it Here: https://www.health.com/beyond-obesity-glp1-8685599 WAYS TO SUPPORT MY WORK ⬇️
Dave sits down with a favorite OTP guest, Dr. Spencer Nadolsky of the Docs Who Lift Podcast to discuss a recent study that asked, “Does Sucralose Increase Hunger?” Dr. Spencer gives his take. Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
In this rare and exclusive interview, the chairman of the Outsourcing Facilities Association sits down with On The Pen to discuss the current landscape of compound tirzepatide. Www.503bs.org
Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
's course, use code “OTP20” to save 20%! https://www.drtyna.com/offers/VstUywXc/checkout Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
Dave discusses the latest in the compound tirzepatide legal battles, cagrisema delivers more big let downs, and some exciting news about VK2735 aka Vikingtide Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
Dr. Catherine Harmon Toomer is a board certified Family Medicine physician, certified hypnotherapist & NLP practitioner, founder of TOTAL Weight Care Institute™️ and Your Light Wellness & Weight Care Group. She provides comprehensive and compassionate alternative to the shame-to-change model & yo-yo progress too often experienced in wellness and weight health spaces. Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
The latest in compounded semaglutide and tirzepatide, as well as the meaning behind World Obesity Day Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
GLP-1 community builder Mike Donnelly-Boylen joins Dave to discuss his health mission and experience losing 100 pounds with Mounjaro! Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
Lilly releases higher dose Zepbound vials, reduces price for patients paying out of pocket. Meanwhile, the tirzepatide lawsuit heats up, with a potential ruing on preliminary injunction. The OFA strikes up a new battle with the FDA, suing them now over the end of the semaglutide shortage. Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
OTP legal expert Lee Thomas joins to discuss the latest in the compound Tirzepatide lawsuit. Dr Simin Lee joins Dave to discuss obesity, GLP-1 medications and heart health! Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
On the 101st episode of On The Pen Live, Dave discusses this week's news in GLP-1, we get weight loss maintenance tips from Korrie, and a Reddit recap from @FitFlavorFun ! For the interview portion, Dave welcomes Charles aka @RoundMoundofZepbound to discuss his health story as well as dealing with a cancer diagnosis after Zepbound weight loss. Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
Breaking Compound Tirzepatide News Lilly announces next generation of GLP-1 / GIP med Trump advocates for cheaper "Fat Shot" HIMS faces industry scrutiny Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
In the 100th episode of On The Pen Live, BJ Davis shares his inspiring 158 lb weight loss journey using Mounjaro, revealing how GLP-1 medications, exercise, and lifestyle changes transformed his life. With insights into the power of community support and expert advice, this milestone episode is a must-listen for anyone interested in sustainable weight loss and the role of GLP-1s in long-term health success! First Episode with BJ: https://www.youtube.com/live/ZrTZGwbNW98 Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
Dave Knapp breaks down what the Q4 Eli Lilly earnings call means for patients living with obesity. https://www.onthepen.com/post/lilly-s-earnings-call-could-reveal-big-changes-for-zepbound-retatrutide-what-they-ve-said-and-wha Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
From high dose semaglutide to cagrisema launch dates, Dave Knapp discusses how the latest Novo Nordisk earnings call impacts patients. Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
Dave covers this week's news in GLP-1 and anti-obesity medicine news. #RETATRUTIDE #ENOBARSARM #zepbound Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
Jamie has lost 463 pounds combining #Ozempic then #Mounjaro #Tirzepatide and Weight Loss Surgery. Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
Lilly to offer higher doses of #Zepbound for less money? New obesity definition High dose #Wegovy trial data APC releases FDA info on enforcement of compounded #tirzepatide Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
With the impending TikTok ban, Dave has invited TikTok creators who are migrating to YouTube to share a little bit about their GLP-1 content that they will be offering on their new channels! #zepbound #mounjaro #tirzeptatide Links To New Creators: @chanelzway @Mike.on.a.Mission2 @mydarlingdaisyhello @jacklemay03 @the_designgirl @breena_727 @Shayla_Kay @TheGLP1HolisticQueen @KeriLeighParker-Mast @lv_doestirzeppy @lisaborders70 @glp1realtalk @Wellness.Scrummaster @GLP1Collective @BrianRantsAboutStuff https://www.obesityaction.org/action-center/access-issues/CMSPublicCommentJanuary2025 Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
https://www.onthepen.com/post/compounders-win-small-battle-in-war-over-zepbound-and-mounjaro-shortages https://www.onthepen.com/post/compounders-win-small-battle-in-war-over-zepbound-and-mounjaro-shortages https://www.obesityaction.org/action-center/access-issues/CMSPublicCommentJanuary2025 Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
Our good friend OTP legal correspondant @LeeFitsIn joins us to give us his expert take on the current lawsuit over the #Zepbound and #Mounjaro shortage lawsuit. Tag Sirius on these posts: https://www.tiktok.com/t/ZP8FAtdpe/ https://www.instagram.com/p/DEniQ5NyRPc/?igsh=bnJrZGZ3ZXpzOWcx https://forum.policiesforpeople.com/t/compound-tirzepatide-and-semaglutide-transparency-in-fda-drug-shortage-process-503b-protection/7821 Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
Dave brings you up to speed on the latest for all GLP-1 compounded medications. https://www.onthepen.com/post/zepound-and-mounjaro-shortage-judge-makes-shocking-move https://forum.policiesforpeople.com/t/compound-tirzepatide-and-semaglutide-transparency-in-fda-drug-shortage-process-503b-protection/7821 Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
Send us a textIn this special Christmas Eve Eve episode of On The Pen: The Weekly Dose, host Dave Knapp dives into groundbreaking updates in GLP-1 medication news, including terzepatide's FDA recognition for resolving obstructive sleep apnea, which could revolutionize insurance coverage for Zepbound. The podcast covers expanded access to generic liraglutide, highlighting its affordability and potential impact on maintenance therapy for obesity and diabetes. Dave also discusses Eli Lilly's victory against unauthorized terzepatide imports, emphasizing patient safety while critiquing the company's approach to compounded medications. Updates on Novo Nordisk's Cagrisema trials reveal investor disappointment despite significant weight-loss results, sparking comparisons with Terzepatide and emerging competitors like Retatrutide. The episode wraps up with exciting giveaways, a review of Dave's book Decoding GLP-1, and insights into protein intake's role in preventing hair loss during rapid weight loss. For the latest in GLP-1 treatments, giveaways, and expert insights, this podcast is your ultimate resource.Decoding GLP-1: A Guide for Friends and Family of Those On The PenBy Dave Knapp
Send us a textBuy The BooK!https://amzn.to/3Bzs4Ggro.co/OTPSupport the showOur Book Has Been Released!Decoding GLP-1: A Guide for Friends and Family of Those On The PenBuy Here: https://amzn.to/3Dc66d4DNF10 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTPUSE CODE "OTP10" to save 10%. A small commission is paid back to support On The Pen!MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:Venmo: OnThePenCa$h App: ManOnMounjaroBECOME A MEMBER:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join
Send us a textIn this special episode of the On The Pen Podcast, I sit down with Shantanu Gaur, the visionary CEO and co-founder of Allurion, to dive deep into the science and innovation behind the Allurion Balloon—a non-surgical, FDA-approved weight loss solution that's transforming the way we approach obesity treatment.We discuss the technology behind this swallowable gastric balloon, its role in reducing food intake and promoting sustainable weight loss, and how Allurion combines cutting-edge tools like a digital companion app, connected scale, and health tracker to support long-term success. Shantanu also shares insights into the company's mission to make weight loss accessible and the future of non-invasive obesity treatments.Whether you're considering weight loss options or curious about the next big leap in obesity care, this episode is packed with expert insights and actionable information. Tune in to learn more about how the Allurion Balloon is helping people achieve transformative results without surgery, and why Shantanu Gaur believes this could be a game-changer in the fight against obesity.ro.co/OTPSupport the showOur Book Has Been Released!Decoding GLP-1: A Guide for Friends and Family of Those On The PenBuy Here: https://amzn.to/3Dc66d4DNF10 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTPUSE CODE "OTP10" to save 10%. A small commission is paid back to support On The Pen!MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:Venmo: OnThePenCa$h App: ManOnMounjaroBECOME A MEMBER:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join
Send us a texthttps://www.onthepen.com/post/novo-nordisk-catalent-deal-approvedSupport the showOur Book Has Been Released!Decoding GLP-1: A Guide for Friends and Family of Those On The PenBuy Here: https://amzn.to/3Dc66d4DNF10 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTPUSE CODE "OTP10" to save 10%. A small commission is paid back to support On The Pen!MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:Venmo: OnThePenCa$h App: ManOnMounjaroBECOME A MEMBER:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join
Send us a textSupport the showDNF10 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTPUSE CODE "OTP10" to save 10%. A small commission is paid back to support On The Pen!MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:Venmo: OnThePenCa$h App: ManOnMounjaroBECOME A MEMBER:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join
Send us a textSupport the showDNF10 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTPUSE CODE "OTP10" to save 10%. A small commission is paid back to support On The Pen!MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:Venmo: OnThePenCa$h App: ManOnMounjaroBECOME A MEMBER:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join
Send us a texthttps://diabetes.org/newsroom/press-releases/american-diabetes-association-announces-statement-compounded-incretinSupport the showDNF10 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTPUSE CODE "OTP10" to save 10%. A small commission is paid back to support On The Pen!MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:Venmo: OnThePenCa$h App: ManOnMounjaroBECOME A MEMBER:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join
Send us a textCEO and Co-Founder of Fractyl Health ($GUTS) Dr. Harith Rajagopalan joins On The Pen to discuss their #Revita and #Rejuva programs for type 2 diabetes and obestityhttps://www.fractyl.com/ro.co/OTPSupport the showDNF10 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTPUSE CODE "OTP10" to save 10%. A small commission is paid back to support On The Pen!MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:Venmo: OnThePenCa$h App: ManOnMounjaroBECOME A MEMBER:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join
Send us a textDr Michael Albert and Dave Knapp discuss the current events in GLP-1 medications as well as the horizon of future anti obesity medicine.ro.co/OTPSupport the showDNF10 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTPUSE CODE "OTP10" to save 10%. A small commission is paid back to support On The Pen!MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:Venmo: OnThePenCa$h App: ManOnMounjaroBECOME A MEMBER:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join
Send us a texthttps://www.onthepen.com/post/medicare-medicaide-to-cover-zepbound-here-s-why-it-s-not-as-simple-as-it-soundsro.co/OTPSupport the showDNF10 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTPUSE CODE "OTP10" to save 10%. A small commission is paid back to support On The Pen!MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:Venmo: OnThePenCa$h App: ManOnMounjaroBECOME A MEMBER:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join
© 2020-2025 Ivy Podcast Discovery LLC
